Atlas Trials

Toripalimab Plus Surgery vs Surgery Alone for Resectable Recurrent Nasopharyngeal Carcinoma

Clinical trial NCT04778956 · RECRUITING

Trial details

NCT number
NCT04778956
Sponsor
Sun Yat-sen University
Status
RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Nasopharyngeal CarcinomaPD-1Surgery
Start date
2021-03-03
Primary completion
2025-03-03
Enrollment
218

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.